Related Experiment Videos
Dissection of regional lymph nodes in cutaneous melanoma
Lancet (London, England)
|July 4, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The treatment of melanoma at Westminster Hospital in the 20th century.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2013
Progress but not enough: the 2009 (7th) revision of the American Joint Committee on Cancer (AJCC) for melanoma staging and classification.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2011
Overexpression of HER-2 in thick melanoma.
Melanoma research·2002
Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients.
European journal of cancer (Oxford, England : 1990)·2002
Serum S100beta protein as a marker of disease activity in patients with malignant melanoma.
Medical oncology (Northwood, London, England)·2002
Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.
Lancet (London, England)·2026
Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study.
Lancet (London, England)·2026
Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care.
Lancet (London, England)·2026
Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.
Cell cycle (Georgetown, Tex.)·2026
Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.
Aging medicine (Milton (N.S.W))·2026
Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.
International journal of nanomedicine·2026
Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.
International journal of pharmaceutics: X·2026
Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.
Materials today. Bio·2026